arrow
M

Manmeet S. Ahluwalia

Miami Cancer Institute
H指数:65
被引数:2.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

SADA-17 SURVIVAL AND LOCAL CONTROL AFTER RESECTION AND GAMMATILE BRACHYTHERAPY FOR NEWLY DIAGNOSED BRAIN METASTASES: A PROSPECTIVE REGISTRY ANALYSIS

SADA-17 新诊断脑转移瘤切除联合伽马瓦片近距离放疗后的生存率与局部控制:一项前瞻性登记分析

2026-08-070
OA
RTAD-06 STEREOTACTIC RADIOSURGERY VERSUS WHOLE BRAIN RADIATION THERAPY IN ELDERLY PATIENTS WITH BRAIN METASTASES: A PROPENSITY SCORE–MATCHED ANALYSIS OF THE NATIONAL CANCER DATABASE (NCDB)

RTAD-06 立体定向放射手术治疗与全脑放射治疗在老年脑转移患者中的比较:基于国家癌症数据库(NCDB)的倾向性评分匹配分析

2026-08-070
OA
DSAI-09 INTERPRETABLE RADIOMICS RISK SIGNATURE FOR DISTINGUISHING TUMOR RECURRENCE FROM RADIATION NECROSIS IN BRAIN METASTASES ON POST-TREATMENT MRI: A COMPARATIVE ANALYSIS WITH ‘BLACK-BOX’ APPROACHES

DSAI-09 用于区分脑转移瘤治疗后MRI上肿瘤复发与放射性坏死的可解释放射组学风险特征:与“黑箱”方法的比较分析

2026-08-070
OA
Anti-LAG-3 with or without anti-PD-1 in recurrent glioblastoma: a phase 1 trial

抗LAG-3抗体联合或不联合抗PD-1抗体治疗复发性胶质母细胞瘤:一项I期临床试验

2026-07-100
OAAI
Tucatinib, trastuzumab, and capecitabine with stereotactic radiosurgery in patients with brain metastases from HER-2 positive breast cancer (TUTOR): Study protocol for a multicenter phase 1 clinical trial

曲拉妥尼、曲妥珠单抗和卡培他滨联合立体定向放射手术在HER-2阳性乳腺癌脑转移患者中的应用(TUTOR):一项多中心I期临床试验研究方案

2025-12-040
OAAI
A PHASE II STUDY OF AZELIRAGON IN COMBINATION WITH RADIATION THERAPY IN NEWLY DIAGNOSED PATIENTS WITH MGMT-UNMETHYLATED GLIOBLASTOMA

一项关于阿泽利龙(Azeliragon)联合放疗治疗新诊断的MGMT未甲基化胶质母细胞瘤患者的II期研究

2025-11-010
OAAI